Nektar’s Novel Eczema Drug Meets Trial Goals, But Differentiation From Dupixent Remains Unclear
Nektar Therapeutics’ biologic drug rezpegaldesleukin take a new approach to atopic dermatitis, or eczema, stimulating…
Nektar’s Novel Eczema Drug Meets Trial Goals, But Differentiation From Dupixent Remains Unclear
Nektar Therapeutics’ biologic drug rezpegaldesleukin take a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses. The drug met the goals of a Phase 2b study, but analysts note that cross-trial measures show those results are short of the marks achieved by Dupixent, the top biologic…
Global Health Funding Awards by State and Congressional District
This resource examines U.S. global health funding awards going to U.S.-based implementers in FY2024, by state and congressional district
5 Takeaways From Health Insurers’ New Pledge To Improve Prior Authorization
Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ practice of denying or delaying doctor-ordered care, the largest U.S. insurers agreed Monday to streamline their often cumbersome preapproval system. Dozens of insurance companies, including Cigna, Aetna, Humana, and UnitedHealthcare, agreed to several measures, which…
From Data Silos to Integrated Care: Driving Provider Engagement
[Sponsored] Explore how integrated workflow solutions—powered by Veradigm’s suite of products—can transform your operations into a more efficient, connected healthcare system. The post From Data Silos to Integrated Care: Driving Provider Engagement appeared first on MedCity News.
Your Guide to Outpatient Addiction Treatment: Top Choices in Sacramento and Beyond
[Sponsored] Unlike inpatient recovery, which requires you to live at a facility full-time, outpatient care allows you to continue working and maintain important relationships while getting necessary care. The post Your Guide to Outpatient Addiction Treatment: Top Choices in Sacramento and Beyond appeared first on MedCity News.
How Smarter Metrics Can Unlock AI’s Potential in Healthcare
Healthcare doesn’t reward shortcuts. It rewards outcomes. AI will play a critical role in shaping those outcomes — but only if leaders measure what truly matters. The best AI implementations elevate expertise, improve quality and create space for innovation. The post How Smarter Metrics Can Unlock AI’s Potential in Healthcare appeared first on MedCity News.
What the New CMS Strategy Signals for Rehab Professionals
The CMS vision is ambitious, but so is the potential for rehab therapy to shape its execution. To do that, providers must actively engage, document their impact, and advocate for their inclusion in evolving models of care. The post What the New CMS Strategy Signals for Rehab Professionals appeared first on MedCity News.
Push To Move OB-GYN Exam Out of Texas Is Piece of AGs’ Broader Reproductive Rights Campaign
Democratic state attorneys general led by those from California, New York, and Massachusetts are pressuring medical professional groups to defend reproductive rights, including medication abortion, emergency abortions, and travel between states for health care in response to recent increases in the number of abortion bans. The American Medical Association adopted a formal position June 9…
‘We Need To Keep Fighting’: HIV Activists Organize To Save Lives as Trump Guts Funding
GREENVILLE, Miss. — Cedric Sturdevant woke up with “a bit of depression” but made it to church, as he does every Sunday. In a few days, he would drive from Mississippi to Washington, D.C., to join HIV advocates at an April rally against the Trump administration’s actions. It had clawed back more than $11 billion…
Ariel Katz, H1
H1 has raised over $200m to build out a very comprehensive data set of physicians internationally. Those products were primarily aimed at pharma. Now they are moving into the world of managing physician data for plans and providers, primarily via the 2025 acquisitions of Ribbon Health and Veda Health. I spoke with CEO Ariel Katz,…
